Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-014375

Chief Development Officer bought 2,946 shares at an average $3.41 ($10,034)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Shemesh Shay Chief Development Officer 2022-02-04 Purchase +2,100 $3.38 $7,098 1,178,769 D: show line 1 in the form
Shemesh Shay Chief Development Officer 2022-02-07 Purchase +846 $3.47 $2,936 1,179,615 D: show line 2 in the form
Open-market purchases · 2,946 sh · avg $3.41 · $10,034
Loading xslF345X03/tm225864-2_4seq1.xml…